Belantamab mafodotin in patients with relapsed/refractory AL amyloidosis with myeloma
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:101 |
---|---|
Enthalten in: |
Annals of hematology - 101(2022), 9 vom: 12. Juli, Seite 2119-2121 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Yifei [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Anmerkungen: |
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 |
---|
doi: |
10.1007/s00277-022-04890-z |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC207934384X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC207934384X | ||
003 | DE-627 | ||
005 | 20230519014734.0 | ||
007 | tu | ||
008 | 221220s2022 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1007/s00277-022-04890-z |2 doi | |
035 | |a (DE-627)OLC207934384X | ||
035 | |a (DE-He213)s00277-022-04890-z-p | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
082 | 0 | 4 | |a 610 |q VZ |
100 | 1 | |a Zhang, Yifei |e verfasserin |4 aut | |
245 | 1 | 0 | |a Belantamab mafodotin in patients with relapsed/refractory AL amyloidosis with myeloma |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 | ||
700 | 1 | |a Godara, Amandeep |4 aut | |
700 | 1 | |a Pan, Stacey |4 aut | |
700 | 1 | |a Toskic, Denis |4 aut | |
700 | 1 | |a Mann, Hashim |4 aut | |
700 | 1 | |a Sborov, Douglas |4 aut | |
700 | 1 | |a Comenzo, Raymond |4 aut | |
700 | 1 | |a Kansagra, Ankit |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annals of hematology |d Springer Berlin Heidelberg, 1991 |g 101(2022), 9 vom: 12. Juli, Seite 2119-2121 |w (DE-627)130956759 |w (DE-600)1064950-5 |w (DE-576)025101188 |x 0939-5555 |7 nnns |
773 | 1 | 8 | |g volume:101 |g year:2022 |g number:9 |g day:12 |g month:07 |g pages:2119-2121 |
856 | 4 | 1 | |u https://doi.org/10.1007/s00277-022-04890-z |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_2018 | ||
912 | |a GBV_ILN_4277 | ||
951 | |a AR | ||
952 | |d 101 |j 2022 |e 9 |b 12 |c 07 |h 2119-2121 |